Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares
Year: 2023
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: Whereas genetic susceptibility for systemic lupus erythematosus (SLE) has been well explored, the triggers for clinical disease flares remain elusive. To investigate relationships between microbiota community resilience and disease activity, we performed the first longitudinal analyses of lupus gut-microbiota communities. METHODS: In an observational study, taxononomic analyses, including multivariate analysis of ß-diversity, assessed time-dependent alterations in faecal communities from patients and healthy controls. From gut blooms, strains were isolated, with genomes and associated glycans analysed. RESULTS: (RG) occurred at times of high-disease activity, and were detected in almost half of patients during lupus nephritis (LN) disease flares. Whole genome sequence analysis of RG strains isolated during these flares documented 34 genes postulated to aid adaptation and expansion within a host with an inflammatory condition. Yet, the most specific feature of strains found during lupus flares was the common expression of a novel type of cell membrane-associated lipoglycan. These lipoglycans share conserved structural features documented by mass spectroscopy, and highly immunogenic repetitive antigenic-determinants, recognised by high-level serum IgG2 antibodies, that spontaneously arose, concurrent with RG blooms and lupus flares. CONCLUSIONS: Our findings rationalise how blooms of the RG pathobiont may be common drivers of clinical flares of often remitting-relapsing lupus disease, and highlight the potential pathogenic properties of specific strains isolated from active LN patients.
Source: Annals of the Rheumatic Diseases
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,870
Funders: Lupus Research Alliance, Immune Tolerance Network, Colton Foundation, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Advancing Translational Sciences
Awards: Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG), Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL), G1814323612, G206071015, G3110267063, G3448428804, G452577285, Institutional Clinical and Translational Science Award, G6065378959, Maternal Autoantibodies: Pathogenesis of Neonatal Lupus, G8023019573, G8463206173, G8583679713, G9000004928, G9000023129, G9000312709, Immune Tolerance Network, Cancer Center Support Grant, Thromboinflammatory pathways triggered by gut dysbiosis in patients with Lupus
OpenAlex ID: W4382046863
